Moderna today released new data that found that a group of participants who had been recently vaccinated had fewer breakthrough cases compared to an earlier cohort of vaccinated people, further demonstrating the immunity of the earlier vaccinated group Has begun to decline in favor of widespread vaccination boosters. As of now, moderna shares are up 1.58% at $434.46.